# A Study of LY3451838 in Participants With Migraine

> **NCT04498910** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 38 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** LY3451838
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04498910
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-16
- **Primary completion:** 2022-11-09
- **Final completion:** 2022-11-09
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04498910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04498910, "A Study of LY3451838 in Participants With Migraine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04498910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*